help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tedeschi, C.
Right arrow Articles by Payne, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tedeschi, C.
Right arrow Articles by Payne, D. W.

Endocrinology, Vol 131, 2476-2478, Copyright © 1992 by Endocrine Society


ARTICLES

Endothelin-1 as a luteinization inhibitor: inhibition of rat granulosa cell progesterone accumulation via selective modulation of key steroidogenic steps affecting both progesterone formation and degradation

C Tedeschi, E Hazum, E Kokia, E Ricciarelli, EY Adashi and DW Payne
University of Maryland School of Medicine, Department of Obstetrics Gynecology, Baltimore.

Endothelin (ET)-1, is a 21 amino acid vasoactive peptide subject to regulation by cellular oxygen tension. However, an increasing body of information now suggests that ET-1 is a multifunctional peptidergic regulator the actions of which are not limited to the vascular system. Although ET-1 has been shown to inhibit the gonadotropin-supported accumulation of progesterone by cultured granulosa cells, the precise cellular mechanism(s) involved remain unknown. It was therefore the objective of this study to examine in greater detail the effects of ET- 1 on progestin economy in cultured granulosa cells from immature rats. Treatment with ET-1 was inhibitory to the FSH-supported accumulation of progesterone in a dose-dependent manner, an action characterized by a median inhibitory dose of 2 x 10(-11) M and a maximal inhibitory effect of 90%. This inhibitory action of ET-1 was reversible following extensive washing and could not be accounted for by a decrease in the viable cell mass. Evaluation of the activities of progesterone-forming enzymes revealed ET-1 to be a potent (P < 0.01) inhibitor of cholesterol side-chain cleavage and 3 beta-hydroxysteroid dehydrogenase (HSD)/isomerase (76.1 +/- 1.2% and 47.3 +/- 8.6% inhibition, respectively). Cellular radiolabeling with [3H]pregnenolone confirmed an ET-1-induced inhibition of the FSH-supported accumulation of radiolabeled progesterone. However, this effect was concomitant with enhancement of the accumulation of more distal metabolites, i.e. 20 alpha-dihydroprogesterone, 5 alpha-pregnane-3 alpha, 20 alpha-diol, and 5 alpha-pregnane-3 alpha-ol-20-one. Analysis of the FSH-supported activities of the progesterone-degrading enzymes revealed ET-1 as a potent (P < 0.05) stimulator of 20 alpha-HSD and 5 alpha-reductase (3.6 +/- 1.0 and 1.7 +/- 0.3-fold, stimulation respectively). In contrast, no significant changes were observed in 3 alpha-HSD activity. Taken together, our findings demonstrate that the ET-1 induced inhibition of gonadotropin-supported progesterone accumulation constitutes a complex phenomenon wherein ET-1 inhibits the activities of steroidogenic enzymes concerned with progesterone formation while enhancing the activities of enzymes concerned with progesterone degradation. We speculate that ET-1, possibly of intraovarian origin, acts as a luteinization-inhibitor to suppress premature luteinization at a time when continued preovulatory expression of ET-1 (in the intact but not ruptured follicle) may be contingent upon relative intrafollicular hypoxia.


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
C.-W. Luo, K. Kawamura, C. Klein, and A. J. W. Hsueh
Paracrine Regulation of Ovarian Granulosa Cell Differentiation by Stanniocalcin (STC) 1: Mediation through Specific STC1 Receptors
Mol. Endocrinol., August 1, 2004; 18(8): 2085 - 2096.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
N. Levy, M. Gordin, M. F. Smith, O. U. Bolden-Tiller, and R. Meidan
Hormonal Regulation and Cell-Specific Expression of Endothelin-Converting Enzyme 1 Isoforms in Bovine Ovarian Endothelial and Steroidogenic Cells
Biol Reprod, April 1, 2003; 68(4): 1361 - 1368.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
L. L. Espey, S. Yoshioka, T. Ujioka, S. Fujii, and J. S. Richards
3{{alpha}}-Hydroxysteroid Dehydrogenase Messenger RNA Transcription in the Immature Rat Ovary in Response to an Ovulatory Dose of Gonadotropin
Biol Reprod, July 1, 2001; 65(1): 72 - 78.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. A. Flores
Gene Expression of Endothelin-1 in the Porcine Ovary: Follicular Development
Biol Reprod, November 1, 2000; 63(5): 1377 - 1382.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
B. D. Murphy
Models of Luteinization
Biol Reprod, July 1, 2000; 63(1): 2 - 11.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
F.M. Young, F.E. Rodger, P.J. Illingworth, and H.M. Fraser
Cell proliferation and vascular morphology in the marmoset corpus luteum
Hum. Reprod., March 1, 2000; 15(3): 557 - 566.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Plonowski, A. K.Kaplinski, M. Radzikowska, M. Borowiec, and B. Baranowska
Correlation between 21 amino acid endothelin, intrafollicular steroids and follicle size in stimulated cycles
Hum. Reprod., September 1, 1999; 14(9): 2323 - 2327.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
G. G. Nussdorfer, G. P. Rossi, L. K. Malendowicz, and G. Mazzocchi
Autocrine-Paracrine Endothelin System in the Physiology and Pathology of Steroid-Secreting Tissues
Pharmacol. Rev., September 1, 1999; 51(3): 403 - 438.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Chamoun, M. D. DeMoura, E. Levitas, C. E. Resnick, S. E. Gargosky, R. G. Rosenfeld, T. Matsumoto, and E. Y. Adashi
Transcriptional and Posttranscriptional Regulation of Intraovarian Insulin-Like Growth Factor-Binding Proteins by Interleukin-1{beta} (IL-1{beta}): Evidence for IL-1{beta} as an Antiatretic Principal
Endocrinology, August 1, 1999; 140(8): 3488 - 3495.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
R. Mamluk, N. Levy, B. Rueda, J. S. Davis, and R. Meidan
Characterization and Regulation of Type A Endothelin Receptor Gene Expression in Bovine Luteal Cell Types
Endocrinology, May 1, 1999; 140(5): 2110 - 2116.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
T. J. Acosta, A. Miyamoto, T. Ozawa, M. P.B. Wijayagunawardane, and K. Sato
Local Release of Steroid Hormones, Prostaglandin E2, and Endothelin-1 from Bovine Mature Follicles In Vitro: Effects of Luteinizing Hormone, Endothelin-1, and Cytokines
Biol Reprod, August 1, 1998; 59(2): 437 - 443.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Mancina, T. Barni, A. E. Calogero, S. Filippi, S. Amerini, A. Peri, T. Susini, G. B. Vannelli, N. Burrello, G. Forti, et al.
Identification, Characterization, and Biological Activity of Endothelin Receptors in Human Ovary
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4122 - 4129.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
G. C. Creatsas, A. B. Malamitsi-Puchner, E. A. Hassan, E. B. Economou, and D. I. Aravantinos
Endothelin Plas{+/-}a Levels in Primary Amenorrheic Adolescents Before and After Estrogen Treatment
Reproductive Sciences, November 1, 1996; 3(6): 350 - 353.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society